cp 122288 has been researched along with serotonin-o-carboxymethyl-gly-tyr in 1 studies
Studies (cp 122288) | Trials (cp 122288) | Recent Studies (post-2010) (cp 122288) | Studies (serotonin-o-carboxymethyl-gly-tyr) | Trials (serotonin-o-carboxymethyl-gly-tyr) | Recent Studies (post-2010) (serotonin-o-carboxymethyl-gly-tyr) |
---|---|---|---|---|---|
17 | 1 | 0 | 20 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castanon, N; Chauveau, J; Chaveau, J; Hen, R; Macor, JE; Moskowitz, MA; Scearce, K; Waeber, C; Yu, XJ | 1 |
1 other study(ies) available for cp 122288 and serotonin-o-carboxymethyl-gly-tyr
Article | Year |
---|---|
5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
Topics: Animals; Capillary Permeability; Dihydroergotamine; Dipeptides; Mice; Mice, Knockout; Pyridines; Pyrroles; Pyrrolidines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion | 1996 |